Together, they explore essential considerations that shape the success of first‑in‑human and early-phase oncology trials:
- Where small biotechs should begin when planning an early-phase oncology trial.
- How to identify the right clinical sites and balance expertise with recruitment potential.
- What to look for when choosing an eCRF/EDC system for small, adaptive early‑phase studies.
Whether you are preparing your first early-phase trial or optimising ongoing oncology programs, this episode provides experience‑driven insights to help sponsors plan smarter and execute with confidence.